Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.

Hacker A, Marton LJ, Sobolewski M, Casero RA Jr.

Cancer Chemother Pharmacol. 2008 Dec;63(1):45-53. doi: 10.1007/s00280-008-0706-x. Epub 2008 Feb 27.

2.

The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer.

Dredge K, Kink JA, Johnson RM, Bytheway I, Marton LJ.

Cancer Chemother Pharmacol. 2009 Dec;65(1):191-5. doi: 10.1007/s00280-009-1105-7. Epub 2009 Aug 15.

PMID:
19685053
3.
4.
5.
6.

Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.

Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW.

Clin Cancer Res. 1995 Aug;1(8):847-57.

7.

The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.

Pledgie-Tracy A, Billam M, Hacker A, Sobolewski MD, Woster PM, Zhang Z, Casero RA, Davidson NE.

Cancer Chemother Pharmacol. 2010 May;65(6):1067-81. doi: 10.1007/s00280-009-1112-8. Epub 2009 Aug 30.

8.

Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells 1.

Casero RA Jr, Mank AR, Saab NH, Wu R, Dyer WJ, Woster PM.

Cancer Chemother Pharmacol. 1995;36(1):69-74.

PMID:
7720179
9.

Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells.

Devereux W, Wang Y, Stewart TM, Hacker A, Smith R, Frydman B, Valasinas AL, Reddy VK, Marton LJ, Ward TD, Woster PM, Casero RA.

Cancer Chemother Pharmacol. 2003 Nov;52(5):383-90. Epub 2003 Jun 25.

PMID:
12827295
10.

Growth status significantly affects the response of human lung cancer cells to antitumor polyamine-analogue exposure.

Carlisle DL, Devereux WL, Hacker A, Woster PM, Casero RA Jr.

Clin Cancer Res. 2002 Aug;8(8):2684-9.

11.

Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells.

Schipper RG, Deli G, Deloyer P, Lange WP, Schalken JA, Verhofstad AA.

Prostate. 2000 Sep 1;44(4):313-21.

PMID:
10951496
14.
15.

Polyamine analogue induction of programmed cell death in human lung tumor cells.

McCloskey DE, Yang J, Woster PM, Davidson NE, Casero RA Jr.

Clin Cancer Res. 1996 Mar;2(3):441-6.

16.

Synthesis and evaluation of a polyamine phosphinate and phosphonamidate as transition-state analogue inhibitors of spermidine/spermine-N1-acetyltransferase.

Wu R, Saab NH, Huang H, Wiest L, Pegg AE, Casero RA Jr, Woster PM.

Bioorg Med Chem. 1996 Jun;4(6):825-36.

PMID:
8818232
18.
19.

Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.

Porter CW, Ganis B, Rustum Y, Wrzosek C, Kramer DL, Bergeron RJ.

Cancer Res. 1994 Nov 15;54(22):5917-24.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk